Proteom

www.proteom.com

Proteom Ltd is a biotechnology company specializing in the in silico design of small molecule ligands. The Company’s state-of-the-art technology platform includes ProtoBuild, a de novo design application, and ProtoScreen, a virtual screening tool.

Proteom currently provides in silico design/screening services to companies requiring cutting edge computational design capabilities for their drug discovery

Staff

Alan Goodman, Chairman Over the last 18 years Alan has founded or co-founded many biotechnology and healthcare companies, including Agricultural Genetics Company, Medeva plc, Chiroscience Group plc, Peptide Therapeutics (now Acambis plc), Oxford BioMedica plc, CeNeS Pharmaceutical plc, Core Group plc and Amura Limited. He was non-executive Chairman of Oxford BioMedica plc and is currently executive chairman of CeNeS Pharmaceutical plc and CEO of Avlar BioVentures Ltd.

Contact details

Articles relating to Proteom

NextGen raises £450,000; reports 40% sales growth in 2006

NextGen sales double in 1H07, operating losses reduced

Cambridge University’s Chemical Engineering, Biotech arms merge

NextGen buys US-based Proteomic Research for $1.7m; completes share placing

NextGen losses widen in 07 but restructuring on track, profits targeted for 1H09

NextGen sales jump 65% as it gears up for assault on US market

Christmas special: update on news snippets from Silicon Fenners released in festive season

Subscribe

 

Corporate profiles

 • Domino Printing

Richard Waddingham MSc, CEng, MIEE Group Technical Director

Domino Printing Sciences Plc was founded in 1978. It has established a global reputation for the continual development and manufacture of ink jet and laser printing technologies that set new industry standards in quality and reliability. Its products print variable data such as 'best before' dates,

[Domino Printing's profile]

Top20 Index

Currently: 71.78

Create Publisher Site
This Publisher Website ( slot3.siliconfenbusiness.com ) does not exist in Direct-Link-Ads.com. Please create it now.